ACR Appropriateness Criteria® definitive external-beam irradiation in stage T1 and T2 prostate cancer Journal Article


Authors: Nguyen, P. L.; Aizer, A.; Assimos, D. G.; D'Amico, A. V.; Frank, S. J.; Gottschalk, A. R.; Gustafson, G. S.; Hsu, I. C. J.; McLaughlin, P. W.; Merrick, G.; Rosenthal, S. A.; Showalter, T. N.; Taira, A. V.; Vapiwala, N.; Yamada, Y.; Davis, B. J.
Article Title: ACR Appropriateness Criteria® definitive external-beam irradiation in stage T1 and T2 prostate cancer
Abstract: Purpose: To present the most updated American College of Radiology consensus guidelines formed from an expert panel on the appropriate use of external-beam radiation to manage stage T1 and T2 prostate cancer. Methods: The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment. Results: The panel summarized the most recent and relevant literature on the topic and voted on 3 clinical variants illustrating the appropriate dose, techniques, and use of adjuvant hormone therapy with external-beam radiation for low-risk, intermediate-risk, and high-risk prostate cancer. Numerical rating and commentary reflecting the panel consensus was given for each treatment approach in each variant. Conclusions: External-beam radiation is a key component of the curative management of T1 and T2 prostate cancer. By combining the most recent medical literature and expert opinion, this guideline can aid clinicians in the appropriate use of external-beam radiation for prostate cancer.
Keywords: treatment; radiotherapy; prostate cancer; radiation therapy; stereotactic body radiotherapy; androgen deprivation therapy; quality-of-life; randomized controlled-trial; phase-iii trial; external-beam radiation; appropriateness criteria; intensity-modulated; dose-escalation trial; conformal radiation-therapy; relapse-free survival; related morbidity
Journal Title: American Journal of Clinical Oncology
Volume: 37
Issue: 3
ISSN: 0277-3732
Publisher: Lippincott Williams & Wilkins  
Date Published: 2014-06-01
Start Page: 278
End Page: 288
Language: English
ACCESSION: WOS:000336958200011
DOI: 10.1097/coc.0000000000000049
PROVIDER: wos
PUBMED: 25180754
Notes: Review -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Yoshiya Yamada
    479 Yamada